NEOG NEOGEN CORP

Nasdaq In Vitro & In Vivo Diagnostic Substances MI CIK: 0000711377
AI RATING
SELL
87% Confidence

Investment Thesis

Neogen faces fundamental operational challenges with zero revenue growth, negative operating income of -$24.7M, and the inability to cover interest expense from operations (interest coverage of -0.6x). Despite adequate liquidity and a strong gross margin, the company's razor-thin net margin (0.5%), minimal free cash flow ($5.7M), and massive EPS decline (-12,475% YoY) indicate deteriorating financial health with an unsustainable debt burden.

Strengths

  • + Strong gross margin of 46.6% indicates viable core product economics
  • + Excellent liquidity position with 3.92x current ratio and $159.9M cash
  • + Positive operating cash flow of $53.0M despite operating losses

Risks

  • ! Negative operating income and inability to cover interest expense (interest coverage -0.6x) indicates unsustainable debt service
  • ! Zero revenue growth with stagnant business and minimal profitability ($3.4M net income on $645M revenue)
  • ! Extremely thin free cash flow margin (0.9%) leaves minimal financial flexibility for investments or economic downturns
  • ! Massive EPS decline of -12,475% YoY signals severe operational deterioration

Key Metrics to Watch

Financial Metrics

Revenue
645.1M
Net Income
3.4M
EPS (Diluted)
$0.02
Free Cash Flow
5.7M
Total Assets
3.4B
Cash
159.9M

Profitability Ratios

Gross Margin 46.6%
Operating Margin -3.8%
Net Margin 0.5%
ROE 0.2%
ROA 0.1%
FCF Margin 0.9%

Balance Sheet & Liquidity

Current Ratio
3.92x
Quick Ratio
2.84x
Debt/Equity
0.38x
Debt/Assets
37.4%
Interest Coverage
-0.65x
Long-term Debt
793.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-13T03:48:21.852480 | Data as of: 2026-02-28 | Powered by Claude AI